Cargando…
Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis
OBJECTIVE: In this cross-sectional study, we aimed to evaluate brain structural abnormalities in relation to glial activation in the same cohort of participants. METHODS: Ten individuals with amyotrophic lateral sclerosis (ALS) and 10 matched healthy controls underwent brain imaging using integrated...
Autores principales: | Alshikho, Mohamad J., Zürcher, Nicole R., Loggia, Marco L., Cernasov, Paul, Chonde, Daniel B., Izquierdo Garcia, David, Yasek, Julia E., Akeju, Oluwaseun, Catana, Ciprian, Rosen, Bruce R., Cudkowicz, Merit E., Hooker, Jacob M., Atassi, Nazem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207001/ https://www.ncbi.nlm.nih.gov/pubmed/27837005 http://dx.doi.org/10.1212/WNL.0000000000003427 |
Ejemplares similares
-
Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [(11)C]-PBR28
por: Zürcher, Nicole R., et al.
Publicado: (2015) -
Imaging of glia activation in people with primary lateral sclerosis
por: Paganoni, Sabrina, et al.
Publicado: (2017) -
Integrated imaging of [(11)C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy (1)H-MRS in amyotrophic lateral sclerosis
por: Ratai, Eva-Maria, et al.
Publicado: (2018) -
Disruption of thalamic functional connectivity is a neural correlate of dexmedetomidine-induced unconsciousness
por: Akeju, Oluwaseun, et al.
Publicado: (2014) -
Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial
por: Babu, Suma, et al.
Publicado: (2021)